Clinical Trials Logo

Clinical Trial Summary

To study and evaluate the effect of using the Primary Relief PENS treatment as adjuvant analgesia for reducing pain in total knee replacement (TKR) patients.


Clinical Trial Description

It is a common knowledge that total knee replacement (TKR) surgeries produce great deal of pain in the postoperative period. Superior pain relief is justifiably needed and usually provided. In addition to the conventional methods of pain relief such as continuous epidural block, intrathecal adjuvants, femoral nerve block ± sciatic nerve block, transcutaneous electrical nerve stimulation (TENS) and percutaneous electrical neurostimulation (PENS) have been reported effective by various authors. Recently neurostimulation of auricular nerves via the external auricular surface has shown to alleviate pain after caesarian section. Primary Relief® is percutaneous electrical neuro stimulator designed to administer auricular neurostimulation treatment over 240 hours. Stimulation is performed by sending electrical pulses emitted through needles strategically positioned in the ear. The ear provides numerous points for stimulation within a small area Based on the area of pain relief, chosen points are stimulated. Primary Relief is a miniaturized device designed to administer PENS treatment. Use of this device is recommended for pre-operative, intra-operative and post-operative pain therapy as well as for the treatment of chronic pain. An advantage over drug therapy is that it avoids the possible side-effects of analgesics and helps in early mobilization following orthopedic surgeries including total knee replacement (TKR), total hip replacement (THR) and shoulder surgeries. Therefore, this study is being undertaken to assess the effect of Primary Relief ® in augmenting pain relief after TKR surgery. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05416294
Study type Interventional
Source DyAnsys, Inc.
Contact
Status Not yet recruiting
Phase N/A
Start date August 15, 2022
Completion date September 30, 2022

See also
  Status Clinical Trial Phase
Completed NCT01226186 - Self Medication With Oral Morphine After Total Knee Arthroplasty. N/A
Terminated NCT01184196 - ChloraPrep Versus Betadine for Elective Knee Replacement Surgery Phase 4
Completed NCT02460172 - Zip® Surgical Skin Closure Device vs. Staples for Skin Closure in Subjects Having Undergone Bilateral Knee Arthroplasty N/A
Not yet recruiting NCT06393075 - The Effectiveness of Combined Care for Knee Replacement Patients N/A
Recruiting NCT06107296 - Early Perioperative Quality Of Recovery After Hip and Knee Arthroplasty: a Retrospective Comparative Cohort Study
Not yet recruiting NCT06407778 - Comparison of High Intensity Strength Training and Muscle Energy Techniques in TKR Patients N/A
Recruiting NCT04152538 - Changes in Quadriceps Muscular Activity in Patients After Total Knee Arthroplasty Compared to Healty Subjects
Terminated NCT03034733 - The Effect of Dexamethasone on Pain After Total Knee Replacement Surgery Phase 4